Maria J. Montoro

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Hair bulb and oral mucosa DNA for prompt germline testing in hematologic neoplasms.

Hair bulb and oral mucosa DNA for prompt germline testing in hematologic neoplasms.

Journal: Blood cancer journal

Published: May 12, 2026

Promoter TERT-Related Hematopoietic Somatic Mosaicism in Patients With Telomere Biology Disorders.

Promoter TERT-Related Hematopoietic Somatic Mosaicism in Patients With Telomere Biology Disorders.

Journal: American journal of hematology

Published: April 22, 2026

Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms.

Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms.

Journal: Blood advances

Published: April 08, 2026

Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

Journal: Blood advances

Published: April 07, 2026

Different SF3B1 Mutation Hotspots Show Hematopoietic Lineage-Specific VAF Patterns and Correlate with Distinct Genetic and Prognostic Profiles in Patients with Myeloid Neoplasms.

Different SF3B1 Mutation Hotspots Show Hematopoietic Lineage-Specific VAF Patterns and Correlate with Distinct Genetic and Prognostic Profiles in Patients with Myeloid Neoplasms.

Journal: Cancers

Published: March 23, 2026

How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

Journal: Leukemia

Published: November 08, 2025

Performance and clinical utility of Spanish germ line genetic testing criteria for hematologic neoplasms predisposition.

Performance and clinical utility of Spanish germ line genetic testing criteria for hematologic neoplasms predisposition.

Journal: Blood advances

Published: October 29, 2025

Performance and Clinical Utility of Spanish Germline Genetic Testing Criteria for Hematologic Neoplasms Predisposition.

Performance and Clinical Utility of Spanish Germline Genetic Testing Criteria for Hematologic Neoplasms Predisposition.

Journal: Blood advances

Published: October 29, 2025

DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study.

DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study.

Journal: Leukemia

Published: May 24, 2025

Myelodysplastic neoplasms with ring sideroblasts without SF3B1 mutations in adults: enrichment of germline variants in congenital sideroblastic anemia genes.

Myelodysplastic neoplasms with ring sideroblasts without SF3B1 mutations in adults: enrichment of germline variants in congenital sideroblastic anemia genes.

Journal: Leukemia

Published: December 12, 2024

Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion.

Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion.

Journal: Blood

Published: January 05, 2024

Germline assessment for alloHSCT candidates over 50 years: A 'Fast-Track' screening in myeloid neoplasms.

Germline assessment for alloHSCT candidates over 50 years: A 'Fast-Track' screening in myeloid neoplasms.

Journal: British journal of haematology

Published: November 10, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026